Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
Welcome to the PlexusDx Education Hub, where we unpack the biology behind longevity protocols, peptide science, and the genetic variables that sit under every aging-related decision. Browse all Peptides & Longevity education to keep reading.
Searchers who type "is NAD+ a peptide" are usually trying to file the molecule under the right heading before they read any further. It is a fair question, because NAD+ turns up constantly in longevity-protocol discussions right alongside genuine peptides. This article draws the line clearly, then explains how NAD+ actually fits into a pathway-based view of aging.
Start a NAD+ protocol with PlexusDx
One all-inclusive price covers your online provider visit, prescription, medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider reviews your fit.
Start your intake →
The direct answer to the classification question
No, NAD+ is not a peptide. Nicotinamide adenine dinucleotide is a coenzyme, and coenzymes belong to a different molecular family than peptides. A peptide is a short chain of amino acids joined by peptide bonds, whereas NAD+ is not an amino-acid chain at all. The two categories get mentioned in the same breath because both surface in longevity and cellular-energy conversations, but chemically they are distinct.
Why the mix-up is common
Longevity protocols tend to bundle several unrelated compounds under one marketing umbrella. When peptides and a coenzyme like NAD+ appear on the same protocol menu, the word "peptide" can drift over to everything on the list. Keeping the categories straight matters, because the biology, the delivery, and the genetic context differ from one class to the next.
Where NAD+ sits in longevity-related biology
NAD+ is discussed in the longevity-protocol space for its role in longevity-related biology. Broadly, compounds in this arena are studied for effects that may touch aging-related biology, cellular energy metabolism, antioxidant defense, and tissue repair, and those effects are mediated through specific enzymatic pathways rather than a single switch. The underlying mechanisms are described in the peer-reviewed literature, while measured effect sizes vary with indication, individual factors, and adherence.
Mechanism versus marketing
It is worth separating what a mechanism can do in principle from what any given protocol delivers in practice. Pharmacology explains the pathway; real-world outcomes depend on the person, the plan, and consistency over time. Calibrating expectations to the clinical literature rather than to testimonials keeps the picture honest.
How PlexusDx frames NAD+ and related compounds
PlexusDx offers NAD+ through its Longevity Protocols, prescribed by licensed providers. The broader Longevity Protocols collection covers the specific compounds the company does offer, and product pages carry current formulation and pricing details for those items. Regardless of which longevity-pathway compound you and your healthcare provider eventually discuss, the underlying genetic architecture stays the same.
The genetic terrain underneath
Variants in FOXO3, SIRT1, and KLOTHO help shape the baseline longevity-related biology that compounds in this space act on. These genes describe pathway-level tendencies; they do not predict how any individual will respond to a specific molecule, and the test is never a way to forecast drug response. What they do is map the metabolic and longevity terrain a clinician is working within. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including variants in FOXO3, SIRT1, and KLOTHO that shape your baseline longevity biology. Reading that profile before committing to any protocol is the test-before-you-invest approach, and it applies through licensed 503A compounding pathways only.
Keep reading on PlexusDx: GLP-1 Hormone, What Is GLP-1, and GLP-1 Receptor Agonist.
Reading longevity labels with a clearer eye
Knowing that NAD+ is a coenzyme and not a peptide is not just pedantry — it changes how you evaluate longevity marketing. A coenzyme and a peptide are studied along different pathways, delivered differently, and carry different genetic considerations. Being able to name what a molecule actually is lets you ask sharper questions of a provider instead of accepting an umbrella label.
The practical upshot is that "peptide protocol" is a marketing bucket, not a chemistry category. When you see NAD+ grouped alongside peptides, treat it as a longevity-adjacent compound with its own distinct biology, and evaluate each item on its own evidence rather than on the shared heading it happens to sit under.
None of this is a verdict on whether NAD+ belongs in a given routine. It is simply a reminder to match the label to the biology: a coenzyme sits in a different category than a peptide, and clear categories make for clearer conversations with a qualified provider. Start from what a molecule is, then ask what the evidence and your own genetic context suggest.
Frequently Asked Questions
If NAD+ is not a peptide, what is it?
NAD+ is a coenzyme called nicotinamide adenine dinucleotide. Peptides are short amino-acid chains, while NAD+ belongs to a separate molecular class entirely. Both appear in longevity-protocol discussions, which is why the two get confused, but they are chemically different and are studied along different pathways.
Does PlexusDx sell NAD+?
No. PlexusDx offers NAD+ through its Longevity Protocols, prescribed by licensed providers. The Longevity Protocols collection lists the specific compounds the company offers, each with its own product page detailing formulation and pricing. For any compound outside that line, discuss options and access with a licensed prescribing provider before making decisions.
Is NAD+ FDA-approved?
FDA approval status depends on the compound and its intended use. Many longevity-protocol applications are off-label or involve compounded products dispensed through licensed 503A pharmacies, which are not FDA-approved as branded drugs. Talk through the regulatory status of any specific product with your prescribing provider before starting.
How does genetic testing relate to NAD+ biology?
The Precision Peptide Genetic Test provides pathway-level context, analyzing variants in FOXO3, SIRT1, KLOTHO, and other genes that shape baseline longevity biology. It does not predict response to NAD+ or any specific compound. Instead, it gives you and your provider upstream information to inform a protocol conversation.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Sermorelin Worth It: Clinical Evidence and Personalization Factors
What Are The Benefits Of Methylene Blue: Clinical Evidence and Provider Context